Regional Cancer Care Associates continues to be a leader in the field of cancer therapy, and four members of the team were recently recognized as among the best in South Jersey.
Each year, South Jersey Magazine asks area physicians which of their peers they would send a family member to, and each year RCCA physicians top the list. Dr. Maurice Cairoli, Dr. Rachel Levenbach and Dr. Stephen Wallace were recently named 2022 Top Docs by South Jersey Magazine. Equally impressive, South Jersey Magazine readers voted Dr. Seth Berk to the 2022 Top Docs patient roll.
These physicians are among RCCA’s more than 90 cancer specialists who treat patients at more than 25 RCCA care centers in New Jersey, Connecticut, Maryland and the Washington, D.C., area. Those oncologists see more than 23,000 new patients each year and provide care to more than 225,000 established patients, collaborating closely with their patients’ other physicians.
They offer patients the latest in cutting-edge treatments, including immunotherapies and targeted therapy, as well as access to a wide range of clinical trials. In addition to serving patients who have solid tumors, blood-based cancers and benign blood disorders such as anemia, RCCA care centers also provide infusion services to people with a number of non-oncologic conditions, including multiple sclerosis, Crohn’s disease, asthma and rheumatoid arthritis.
To learn more about RCCA, call 844-928-0089 or visit RCCA.com.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Black Americans with lung cancer are 18% less likely than white people to be diagnosed in the early stages of the disease, 23% less likely to receive surgery, and 21% less likely to survive 5 years after diagnosis, according to the American Lung Association.
Cancer can affect anyone from any background. However, some racial and ethnic groups have higher rates of certain kinds of cancer. Regional Cancer Care Associates
Infusion therapy is a treatment modality that administers medications intravenously. While most people associate infusions with cancer treatment, several different conditions can be managed and
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.
